References
- Bruno B Gooley T Hackman RC Davis C Corey L Boeckh M Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival Biol Blood Marrow Transplant 2003 9 5 341 352 12766884
- Elion GB Furman PA Fyfe JA de Miranda P Beauchamp L Schaeffer HJ The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Reproduced from Proc Natl Acad. Sci U S A. 1977;74:5716–5720 Rev Med Virol 1999 9 3: 147 152 discussion 152–153 10479776
- Shiota H Naito T Mimura Y Anti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit cornea Curr Eye Res 1987 6 1 241 245 3030645
- Castela N Vermerie N Chast F Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy J Ocul Pharmacol 1994 10 2 439 451 8083563
- Tirucherai GS Dias C Mitra AK Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design J Ocul Pharmacol Ther 2002 18 6 535 548 12537680
- Castela N Vermerie N Chast F Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy J Ocul Pharmacol 1994 10 2 439 451 8083563
- Fresta M Fontana G Bucolo C Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir J Pharm Sci 2001 90 3 288 297 11170022
- Wilson CG Zhu YP Frier M Rao LS Gilchrist P Perkins AC Ocular contact time of a carbomer gel (GelTears) in humans Br J Ophthalmol 1998 82 10 1131 1134 9924298
- Elftman MD Hunzeker JT Mellinger JC Bonneau RH Norbury CC Truckenmiller ME Stress-induced glucocorticoids at the earliest stage of herpes simplex virus-1 infection suppress subsequent antiviral immunity, implicating impaired dendritic cell function J Immunol 2010 184 4 1867 1875 20089700
- Tabbara KF Treatment of herpetic keratitis Ophthalmology 2005 112 9 1640 16139674
- Green LK Pavan-Langston D Herpes simplex ocular inflammatory disease Int Ophthalmol Clin 2006 46 2 27 37 16770152
- Tullo A Pathogenesis and management of herpes simplex virus keratitis Eye (Lond) 2003 17 8 919 922 14631397
- Colin J Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes Clin Ophthalmol 2007 1 4 441 453 19668521
- Zirgan®(ganciclovir) [package insert] Rochester, NY Bausch and Lomb, Inc 2009
- Kaufman HE Haw WH Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis Curr Eye Res 2012 37 7 654 660 22607463
- Kaufman HE Ganciclovir: a promising topical antiviral gel for herpetic keratitis Expert Rev Ophthalmol 2009 4 4 367 375
- Croxtall JD Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers) Drugs 2011 71 5 603 610 21443283
- Hoh HB Hurley C Claoue C Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study Br J Ophthalmol 1996 80 2 140 143 8814744
- Fu J Feng X Yuan H Study of ocular pharmacokinetics of in situ gel system for S(−)-satropane evaluated by microdialysis J Pharm Biomed Anal 2008 48 3 840 843 18632240
- Mundada AS Avari JG In situ gelling polymers in ocular drug delivery systems: a review Crit Rev Ther Drug Carrier Syst 2009 26 1 85 118 19496748
- Gratieri T Gelfuso GM Rocha EM Sarmento VH de Freitas O Lopez RF A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery Eur J Pharm Biopharm 2010 75 2 186 193 20188828
- Ammar HO Salama HA Ghorab M Mahmoud AA Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery Drug Dev Ind Pharm 2010 36 11 1330 1339 20545523
- Kumar S Himmelstein KJ Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose J Pharm Sci 1995 84 3 344 348 7616375
- Edsman K Carlfors J Harju K Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use Int J Pharm 1996 137 2 233 241